Orthopediatrics SEC filings: 8-K

Filter: All · 8-K · 10-Q · 10-K · Form 4

8-KOct. 27, 2026, 4:15 p.m. ETView on SEC.gov
Regulation FD disclosure · Financial statements and exhibits
AI summary, unreviewedOrthoPediatrics Investor Presentation (Ex. 99.1) Reiterates FY2026 Revenue Guidance of $270.0 to $273.0 Million and Shows 3Q 2026 Revenue Up 19% to $72.7 Million
8-KOct. 27, 2026, 4:07 p.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits
AI summary, unreviewedOrthoPediatrics Q3 2026 Revenue Rises 19% to Record $72.7 Million, Beats $68.5 Million Consensus; Adjusted EPS of -$0.23 Misses -$0.21 Estimate; Raises FY2026 Revenue Guidance to $270.0-$273.0 Million
8-KAug. 4, 2026, 4:31 p.m. ETView on SEC.gov
Regulation FD disclosure · Financial statements and exhibits
8-KAug. 4, 2026, 4:08 p.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits